当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Journal of Experimental & Clinical Cancer Research杂志
Journal of Experimental & Clinical Cancer Research
基本信息
期刊名称 Journal of Experimental & Clinical Cancer Research
J EXP CLIN CANC RES
期刊ISSN 1756-9966
期刊官方网站 http://jeccr.biomedcentral.com
是否OA Yes
出版商 BioMed Central
出版周期 Quarterly
文章处理费 登录后查看
始发年份 2008
年文章数 280
影响因子 11.4(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 ONCOLOGY 肿瘤学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 5.34 1.761 1.277
Biochemistry, Genetics and Molecular Biology
Cancer Research
32 / 191 83%
Medicine
Oncology
35 / 321 88%
补充信息
自引率 1.8%
H-index 67
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-9966%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/jecc/
收稿范围
Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside.

Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer.

Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.

The following criteria provide an overview of the types of studies considered by the journal:

Findings that have not been previously published in the same tumor model.
Studies performed in multiple cell lines.
Conclusions that are not representative of incremental findings.
Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts.
The online appearance of Journal of Experimental & Clinical Cancer Research allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.
收录体裁
Research articles
Review
Commentary
Meeting report
投稿指南 http://jeccr.biomedcentral.com/submission-guidelines
投稿模板 https://jeccr.biomedcentral.com/submission-guidelines/preparing-your-manuscript
参考文献格式 https://jeccr.biomedcentral.com/submission-guidelines/preparing-your-manuscript
编辑信息

Editor-in-Chief 
Mauro Castelli, Regina Elena National Cancer Institute, Italy

Deputy Editor
Gabriella D'Orazi, University of Chieti, Italy 

Assistant Editor
Silvia Di Agostino, Regina Elena National Cancer Institute, Italy

Managing Editor
Alice Castelli, Regina Elena National Cancer Institute, Italy 

Associate Editor
Giovanni Blandino, Regina Elena National Cancer Institute, Italy
George Calin, MD Anderson Cancer Center, USA
Maria Lauda Tomasi, University of Southern California, USA

Editorial Board
Eiman Aleem, University of Arizona College of Medicine, Phoenix, USA
Michael Andreeff, MD Anderson Cancer Center, USA
Anna Bagnato, Regina Elena National Cancer Institute, Italy
Gianluca Bossi, Regina Elena National Cancer Institute, Italy
Cornelia Braicu, Iuliu Hatieganu University of Medicine and Pharmacy, Romania
Christian Bronner, Institut Génétique Biologie Moléculaire Cellulaire, France 
Michele Caraglia, Second University of Naples, Italy 
Ye-Guang Chen, Tsinghua University, China
Gaetana Cognetti, Regina Elena National Cancer Institute, Italy 
Bingbing Dai, MD Anderson Cancer Center, USA
Francesca Di Modugno, Regina Elena National Cancer Institute, Italy
Massimo Donadelli, University of Verona, Italy
Luigi Fattore, University of Sapienza, Italy
Armando Felsani, National Research Council, Italy
Giulia Fontemaggi, Regina Elena National Cancer Institute, Italy 
Antonio Giordano, Temple University, USA
Fernand Gobeil, University of Sherbrooke, Canada
Ramakrishnan Gopalakrishnan, University of Southern California, USA
Matthias Ilmer, Ludwig Maximilian University of Munich, Germany
Jolanta Jura, Jagiellonian University, Poland
Carlo Leonetti, Regina Elena National Cancer Institute, Italy 
Fengzhi Li, Roswell Park Cancer Institute, USA
Yong Lu, Henry Ford Neuroscience Institute, USA
Andrew Reay MacKay, University of L'Aquila, Italy
Michele Maio, Istituto Toscano Tumori, Italy
Rita Mancini, University of Sapienza, Italy
Anna Maria Mileo, Regina Elena National Cancer Institute, Italy
Paola Muti, McMaster University, Canada
Nicola Normanno, Pascale Cancer Institute, Italy
Marco G Paggi, Regina Elena National Cancer Institute, Italy
Alessandro Porrello, University of North Carolina, USA
Chiara Riganti, University of Torino, Italy
Anand Rotte, Genentech Research and Early Development, USA
Erica Salvati, Regina Elena National Cancer Institute, Italy 
Silvia Soddu, Regina Elena National Cancer Institute, Italy 
Sabrina Strano, Regina Elena National Cancer Institute, Italy 
Rong-Hua Tao, MD Anderson Cancer Center, USA
Yong Teng, Augusta University, USA
Aldo Venuti, Regina Elena National Cancer Institute, Italy 
Go Yoshida, Tokyo Medical and Dental University, Japan
Tianhua Zhou, Zhejiang University, China


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug